Table: Garna Biosciences -Q1 group results

Carna Biosciences

10/05/2021 07:30

May 10 (Reuters)- 
             Garna Biosciences Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to   
                Mar 31, 2021        Mar 31, 2020       Dec 31, 2021  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Sales            231 mln             335 mln           923 mln     
                 (-31.0 pct)         (+97.1 pct)       (-18.5 pct)   
  Operating     loss 291 mln        loss 165 mln        loss 1.81    
  Recurring     loss 284 mln        loss 168 mln        loss 1.82    
  Net           loss 286 mln        loss 184 mln        loss 1.83    
  EPS          loss 23.09 yen      loss 15.25 yen    loss 147.19 yen 
  Ann Div                                NIL               NIL       
  -Q2 div                                NIL               NIL       
  -Q4 div                                NIL               NIL       
  
  NOTE - Garna Biosciences Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4572.T